HebeCell lands $53M, Chinese collaborator to make a splash in busy CAR-NK space
HebeCell lands $53M, Chinese collaborator to make a splash in [...]
HebeCell lands $53M, Chinese collaborator to make a splash in [...]
After cutting dose because of deaths, Astellas pauses gene therapy [...]
J&J’s HIV vaccine fails phase 2b, extending long wait for [...]
GSK, Korean biotech SK go head-to-head against AstraZeneca’s COVID-19 shot [...]
A year after a death and accompanying trial hold, Poseida [...]
The descent of van de Stolpe: Galapagos CEO exits after [...]
Brain cancer biotech Ziopharm snaps up new CEO from Kuur [...]
Pfizer’s abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, [...]
SPAC backs Revelation to tackle respiratory viral infections ntaylor Mon, [...]
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce [...]